Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments
McGill University researchers have built tiny particle carriers that can shuttle cancer drugs straight to diseased lymph nodes without touching healthy tissue, reducing toxic side effects in mice compared to conventional whole-body treatment. The method tackles cancer that has spread into the lymphatic system, a particularly tough stage that typically forces surgeons to remove affected nodes despite their essential role in coordinating immune responses throughout the body. Standard immunotherapy floods the bloodstream through IV infusion, activating immune responses indiscriminately across organs and tissues in ways that can grow dangerous enough to require dose cuts that weaken treatment. McGill Biomedical Engineering Assistant Professor Guojun Chen says certain immunotherapies trigger reactions so…

